Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Health & Life Sciences

Overview

As a stakeholder in the health and life sciences sector, you work every day to improve human health and enhance patient care. Our national health and life sciences team partners with industry leaders like you — biotech innovators, pharmaceutical and medical device manufacturers, health systems, investors, and digital health pioneers — to help you thrive in a landscape defined by rapid change and increasingly complex regulatory demands.

Our professionals have extensive practical experience to help you navigate the sector’s most critical business and legal challenges. We advise on transformative mergers and acquisitions, strategic investments, and capital deployment, ensuring your transactions are efficient and positioned for long-term growth and innovation. Our team handles high-stakes litigation and government investigations, providing sophisticated advocacy and clear strategic guidance when challenges arise.

We support you throughout the business life cycle — structuring and negotiating technology transactions, licensing, and collaborations; guiding you through complex regulatory requirements at all stages of the product lifecycle; and implementing proactive risk management and compliance solutions. Our capabilities also encompass employee benefits and executive compensation, privacy and data security, outsourcing, intellectual property, and public policy strategy, helping you seize opportunities and mitigate risk in every aspect of your operations.

Our team includes former in-house counsel to major health systems and global life sciences companies, as well as former FDA, other federal agency and Capitol Hill health policy advisors, and former Department of Justice attorneys. With this blend of industry insight and legal acumen, we deliver practical, business-minded solutions tailored to your most complex challenges so you can continue advancing your mission and achieving your strategic objectives in a rapidly evolving sector.

Insights & Events

Latest

Updates January 2026

Three District Courts Quash DOJ Subpoenas Investigating Gender-Affirming Care

Federal Courts Demand Proper Purpose for DOJ Inquiries Into Gender-Affirming Treatments
9 min read
Updates January 2026

Top 10 Noncompete Developments of 2025

A Year of Contrasts and Crackdowns in Noncompete Agreements
12 min read
Media Mentions December 2025

Scott Kosnoff Comments on Executive Order Preempting State AI Regulation With Indiana Lawyer

1 min read
Updates December 2025

Significant Drug & Device Developments of 2025

Drug & Device Companies Need to Be Vigilant and Nimble in Adapting to These Shifts
17 min read
Press Release December 2025

Faegre Drinker Welcomes Labor & Employment Counsel Stephanie Albrecht in Los Angeles

2 min read
Updates December 2025

UK Immigration: 2025 Summary

How Sponsors Can Maintain Compliance and Avoid the Consequences of Breach
10 min read
Updates December 2025

European Union’s Digital Omnibus Package, Part II — Changes to the GDPR and the Data Act

Key Changes Relevant to U.S. Businesses
9 min read
News November 2025

Faegre Drinker Recognized Among Top Antitrust Firms in GCR 100 for 2026

1 min read
Speaking Engagement Recap November 08, 2025

The Impact of AI on the Pharmacy Industry: Managing its Risks and Benefits

American Society for Pharmacy Law: 2025 Developments in Pharmacy Law
1 min read
Speaking Engagement Recap November 07, 2025

Data, Dangers, & Developments in Drug Supply Chain Security & Safety

American Society for Pharmacy Law: 2025 Developments in Pharmacy Law
1 min read
Insights
Updates January 2026

Three District Courts Quash DOJ Subpoenas Investigating Gender-Affirming Care

Federal Courts Demand Proper Purpose for DOJ Inquiries Into Gender-Affirming Treatments
9 min read
Updates January 2026

Top 10 Noncompete Developments of 2025

A Year of Contrasts and Crackdowns in Noncompete Agreements
12 min read
Media Mentions December 2025

Scott Kosnoff Comments on Executive Order Preempting State AI Regulation With Indiana Lawyer

1 min read
Updates December 2025

Significant Drug & Device Developments of 2025

Drug & Device Companies Need to Be Vigilant and Nimble in Adapting to These Shifts
17 min read
Updates December 2025

UK Immigration: 2025 Summary

How Sponsors Can Maintain Compliance and Avoid the Consequences of Breach
10 min read
Updates December 2025

European Union’s Digital Omnibus Package, Part II — Changes to the GDPR and the Data Act

Key Changes Relevant to U.S. Businesses
9 min read
Published Articles November 2025

Navigating FDA Regulatory and Litigation Risks With Al-Enabled Medical Devices and Non-Device Software: A Landscape Analysis for Medical Product Counsel

Defense Research Institute’s For the Defense
1 min read
Updates November 2025

The European Union’s Digital Omnibus and Its Impact on Artificial Intelligence

Significant Proposed Changes to Legislation Covering AI, Data Privacy and Cybersecurity
7 min read
Updates November 2025

Potential Challenges to State AI Laws; Senate Hearing on AI; and More Developments

Artificial Intelligence Briefing
6 min read
Updates November 2025

Earned Settlement — Reshaping the UK’s Settlement System

‘The Settlement Hunger Games’
10 min read

Meet The Team

Meet The Full Health & Life Sciences Team